Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42001719EBVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS10006549HBVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS10008067HBVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS10008068HBVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30003991HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30079115HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30087748HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30081211HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30081546HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30082146HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TCGA Plot Options
Drug Information
GeneEGFR
DrugBank IDDB09559
Drug NameNecitumumab
Target IDBE0000767
UniProt IDP00533
Regulation Typeantagonist
PubMed IDs20197484
CitationsKuenen B, Witteveen PO, Ruijter R, Giaccone G, Dontabhaktuni A, Fox F, Katz T, Youssoufian H, Zhu J, Rowinsky EK, Voest EE: A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies. Clin Cancer Res. 2010 Mar 15;16(6):1915-23. doi: 10.1158/1078-0432.CCR-09-2425. Epub 2010 Mar 2.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBL